Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-01 Sale | 2023-03-03 08:01 am | Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President | 91,868 | $0.8775 | $80,614 | 1,888,728 (Indirect Direct) | View |
| 2023-02-27 Sale | 2023-03-01 4:07 pm | Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President | 38,632 | $0.8132 | $31,416 | 1,980,596 (Indirect Direct) | View |
| 2022-06-14 Sale | 2022-06-16 9:48 pm | Zynerba Pharmaceuticals Inc. | ZYNE | Butler John P. Director | 53 | $1.01 | $54 | 67,719 (Direct) | View |
| 2022-02-28 Sale | 2022-03-02 9:25 pm | Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President | 79,026 | $2.1657 | $171,143 | 2,462,803 (Indirect Direct) | View |
| 2021-04-01 Sale | 2021-04-01 8:32 pm | Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President | 4,109 | $3.4 | $13,971 | 1,534,103 (Indirect Direct) | View |
| 2021-03-01 Sale | 2021-03-02 4:10 pm | Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President | 49,990 | $3.3961 | $169,771 | 1,902,292 (Indirect Direct) | View |
| 2019-11-20 Purchase | 2019-11-21 06:32 am | Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President | 50,000 | $3.44 | $172,000 | 1,069,682 (Indirect Direct) | View |
| 2018-08-22 Purchase | 2018-08-22 4:39 pm | Zynerba Pharmaceuticals Inc. | ZYNE | Butler John P. Director | 5,000 | $6.4306 | $32,153 | 5,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-01-31 Option Award | 2023-02-02 4:15 pm | N/A 2033-01-31 | Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President | 1,803,438 | $0 | 3,529,541 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 9:48 pm | N/A 2032-06-14 | Zynerba Pharmaceuticals Inc. | ZYNE | Butler John P. Director | 57,772 | $0 | 67,719 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 9:25 pm | N/A 2032-02-28 | Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President | 1,032,825 | $0 | 2,462,803 (Direct) | View |
| 2018-12-12 Other(A) | 2022-02-18 9:55 pm | N/A N/A | Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President | 1,248 | $0 | 377,113 (Direct) | View |
| 2021-08-03 Option Award | 2021-08-05 5:28 pm | N/A 2031-08-03 | Zynerba Pharmaceuticals Inc. | ZYNE | Butler John P. Director | 12,500 | $0 | 17,500 (Direct) | View |
| 2021-03-16 Option Award | 2021-03-18 7:17 pm | N/A N/A | Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President | 39,520 | $0 | 1,538,212 (Direct) | View |
| 2021-02-26 Option Award | 2021-03-02 4:10 pm | N/A 2031-02-26 | Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President | 641,000 | $0 | 1,902,292 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-11 5:40 pm | N/A 2030-06-10 | Zynerba Pharmaceuticals Inc. | ZYNE | Butler John P. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-02 7:26 pm | N/A 2030-02-28 | Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President | 641,000 | $0 | 1,712,182 (Direct) | View |
Ownership | 2020-02-14 5:03 pm | N/A N/A | Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President | 0 | $0 | 1,071,182 (Direct) | View |
| 2019-06-11 Option Award | 2019-06-13 4:19 pm | N/A 2029-06-11 | Zynerba Pharmaceuticals Inc. | ZYNE | Butler John P. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2019-06-03 Exercise | 2019-06-05 4:05 pm | N/A 2023-09-16 | Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President | 287,000 | $0 | 1,018,182 (Direct) | View |
| 2019-06-03 Exercise | 2019-06-05 4:05 pm | N/A N/A | Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President | 287,000 | $0.47 | 1,018,182 (Direct) | View |
| 2019-02-28 Option Award | 2019-03-05 4:05 pm | N/A 2029-02-28 | Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President | 589,500 | $0 | 1,081,182 (Direct) | View |
| 2018-12-12 Tax Withholding | 2018-12-13 08:10 am | N/A N/A | Akebia Therapeutics Inc. | AKBA | Butler John P. CEO & President | 135,697 | $8.94 | 491,417 (Direct) | View |
| 2018-07-11 Exercise | 2018-07-12 4:59 pm | N/A 2023-09-16 | Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President | 100,000 | $0 | 797,314 (Direct) | View |
| 2018-07-11 Exercise | 2018-07-12 4:59 pm | N/A N/A | Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President | 100,000 | $0.47 | 797,314 (Direct) | View |
| 2018-06-06 Option Award | 2018-06-07 4:30 pm | N/A 2028-06-06 | Zynerba Pharmaceuticals Inc. | ZYNE | Butler John P. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2018-04-12 Option Award | 2018-04-16 4:15 pm | 2018-04-12 2028-04-12 | Zynerba Pharmaceuticals Inc. | ZYNE | Butler John P. Director | 35,000 | $0 | 35,000 (Direct) | View |